Vanderbilt University: Clinical Center Application, Type 1 Diabetes TrialNet
Description: PUBLIC HEALTH RELEVANCE: Type 1 diabetes (T1D), which is caused by immune system destruction of the insulin-producing cells of the pancreas, affects as many as 3 million Americans of all ages, including the majority of the 215,000 children under the age of 20 who have diabetes. The incidence of T1D has been increasing 3-5% per year for decades, most rapidly among toddlers, and the disease has an immense impact on the economy as well as on the lives of those who must live with the disease. Vanderbilt University passionately endorses the mission of the Type 1 Diabetes TrialNet consortium to identify individuals at risk to develop T1D and to engage them to enter into clinical trials to develop a strategy to prevent them and future generations from developing T1D, and, in the process, engaging an even greater number of young investigators to enter the field of T1D prevention research.
Funding type: cooperative_agreement
Funder scheme: U01
Start date: 2009-09-30
End date: 2020-04-30
Investigator: WILLIAM E RUSSELL
Institution: VANDERBILT UNIVERSITY MEDICAL CENTER
Subfield: Genetics
Domain: Life Sciences
Funded outputs count: 156
Funder award ID: U01DK085465
OpenAlex ID: G599242060